Completed
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903
NCT06846099
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +26 more
- Locations
-
- Beijing Cancer Hospital Beijing, China
- The First Affiliated Hospital of Bengbu Medical College Bengbu, China
- Jilin Cancer Hospital Changchun, China
- Jilin University First Hospital Changchun, China